Preview complete
The prescreener preview is complete. You may now close the preview.
AI-powered
Trial T02
Study on the Effects of an Investigational Treatment for Hypertension
B
Bulk Inv
Primary Investigator
Recruiting
18 years - 86 years
Transgender
Phase
1
120 participants needed
3 Locations
Brief description of study.
- asdsadsadasdasdas
- dsfsfsdf
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Acne
-
Age: 18 years - 86 years
-
Gender: Transgender
Inclusion Criteria:
Exclusion Criteria:
Updated on
19 Feb 2024.
Study ID: IRB_01
- Who can participate: Adults aged 18 to 65 with a diagnosis of hypertension, who are otherwise healthy, are eligible to participate.
- Study details: Participants will be required to take the investigational medication daily and attend regular clinic visits for monitoring and assessments.
Pre-Screener
